TelyRx Holdings Inc. is making waves on the TSX with a remarkable 5.60% increase in just one trading day.
TelyRx Holdings Inc. (TELY.TO) saw its stock price jump by 5.60% in the latest trading session, closing at CA$2.64. This rise follows some exciting company news and a strong performance in the healthcare sector.
Advertisement
Earn cash back with a smarter spending account
Open a KOHO account and start earning on everyday purchases — no annual fee on the base plan.
TelyRx Holdings Inc.
TELY.TO
TELY.TO
TelyRx Holdings Inc.
WealthAwesomeMarket cap
$73.09M
52W high
$4.25
52W low
$2.00
1W change
-4.51%
Analyst Price Targets
Based on analyst covering TELY
Wall Street analysts forecast TELY stock price to rise 118.2% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$6.00
+118.2% Upside
Current Price
C$2.75
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TELY's historical volatility
30-Day Vol
107.5%
Annualized
90-Day Vol
102.2%
Annualized
Trend (90d)
-36.5%
Annualized drift
90d Mean
C$2.41
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$2.63 | C$1.82 – C$3.82 |
| 60 trading days | C$2.52 | C$1.49 – C$4.26 |
| 90 trading days | C$2.41 | C$1.27 – C$4.59 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Keep an eye on TelyRx as it expands its market presence and engages with investors through upcoming events.
TelyRx Holdings Inc. sees a 5.60% increase in stock price.
With a market cap of CA$66.4 million, TelyRx is positioned for growth but faces profitability challenges.
Bull case
The company recently hit a significant milestone by filling over one million prescriptions. Its participation in the Global Technology Virtual Investor Conference is also a promising sign of growth potential and investor interest.
Bear case
Despite the positive movement, TelyRx's negative profit margin and the risks in the healthcare sector could challenge its ability to maintain growth.
Advertisement
Recent Milestones Fueling Growth
TelyRx recently celebrated filling over one million prescriptions since its launch. This achievement showcases the company's operational capabilities and its expanding presence in the healthcare sector. Additionally, TelyRx will present at the Global Technology Virtual Investor Conference on July 9th, which is expected to draw more investor interest.
Market Performance and Future Outlook
The stock's 5.60% increase reflects positive market sentiment towards TelyRx, especially as it continues to grow its services across the U.S. However, potential investors should consider the company's current profit margin challenges alongside its growth prospects. With a market cap of CA$66.4 million, TelyRx is at a crucial point where strategic decisions will shape its future.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
